Brief: 'Enhanced Lung Rest' With Cytosorb And Ecmo Achieves High Survival In 100 Critically-ill Covid-19 Patients
02/11/2022 11:35
Nov 2 (Reuters) - Cytosorbents Corp CTSO.O :
* 'ENHANCED LUNG REST' WITH CYTOSORB AND ECMO ACHIEVES HIGH
SURVIVAL IN 100 CRITICALLY ILL COVID-19 PATIENTS WITH REFRACTORY
LUNG FAILURE FROM FIVE MAJOR U.S. HOSPITALS
Source text for Eikon: ID:nPn6YRdLfa
Further company coverage: CTSO.O
((Reuters.Briefs@thomsonreuters.com;))